Winners
Slop Merchants - New AI video makers foreshadow a wave of slop to make 2024 Facebook blush.
Ozempic Users - Mass marketed but not viewed as low status. It is an acceptable way to lose weight. We are still in the early stages of adoption.
Federal Judges - Who runs bartertown! The left keeps setting up a flip the game board moment.
Losers
Harvard - Money woes. Trump admin making an example of them. Is this to get every other college to comply?
Foreign students - The turnstile is blocked. An announcement noted the idea of reviewing social media accounts. Good luck third worldist lefties!
Small Private Universities - Harvard can weather a storm. If small universities lose the foreign student influx, how do they make up the revenue? More kids realize college is a scam. How do they lure them to attend?
Links
Another left-wing manifesto to read.
One thing I never really hear about in the GLP-1 discussion (Ozempic, Wegovy, Mounjaro) is the risks to the endocrine system, especially for patients with very high and/or long-term dosages.
My step-dad just had a major gall-bladder scare, just a month after they upped him to max dosage. The ER doctors treating him say it's not related, but the known side effects lists gallbladder disease as a side effect in 1 out of 200 patients, which seems pretty high?
> Federal Judges - Who runs bartertown! The left keeps setting up a flip the game board moment.
Ah the old leftist insistence that *checks notes* the president isn't allowed to unilaterally raise taxes.